FDA Approves Cannabidiol for Tuberous Sclerosis Complex FDA Approves Cannabidiol for Tuberous Sclerosis Complex

The US Food and Drug Administration has expanded its approval for cannabidiol (Epidiolex) oral solution to also treat seizures in tuberous sclerosis complex for patients aged 1 year and older.FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news